İçeriğe geç
akaturk Akademik ölçüm

Akademisyen profili · PROFESÖR

AHMET GÖKHAN ÖZGEN

EGE ÜNİVERSİTESİ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Endokrinoloji ve Metabolizma Hastalıkları (İç Hastalıkları)
  • TIP FAKÜLTESİ
  • DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Makale YÖKSİS 300
Proje 1
Kitap 2
Bildiri 282
Patent 1
Sanatsal 1
Scopus (SJR)
Q1 67 Q2 114 Q3 13 Q4 21
WoS (JCR)
Q1 6 Q2 51 Q3 64 Q4 94
TR Index 46 makale

Scopus (SJR)

Q1 67 Q2 114 Q3 13 Q4 21

WoS (JCR)

Q1 6 Q2 51 Q3 64 Q4 94

TR Index

46 makale

Toplam 300 yayın

Makaleler

  1. 2023 Stemness potency and structural characteristics of thyroid cancer cell lines. Pathology, research and practice DOI 10.1016/j.prp.2022.154262
  2. 2023 The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line. Pathology, research and practice DOI 10.1016/j.prp.2023.154385
  3. 2023 Stemness potency and structural characteristics of thyroid cancer cell lines Elsevier BV DOI 10.1016/j.prp.2022.154262
  4. 2023 Stemness potency and structural characteristics of thyroid cancer cell lines Pathology Research and Practice DOI 10.1016/j.prp.2022.154262
  5. 2023 Stemness potency and structural characteristics of thyroid cancer cell lines PATHOLOGY RESEARCH AND PRACTICE DOI 10.1016/j.prp.2022.154262
  6. 2023 Evaluation of IL-10, MCP-1, IFN gamma, and protectin D1 levels in patients with Hashimoto's thyroiditis IRISH JOURNAL OF MEDICAL SCIENCE DOI 10.1007/s11845-022-03231-3
  7. 2023 The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line PATHOLOGY RESEARCH AND PRACTICE DOI 10.1016/j.prp.2023.154385
  8. 2023 Stemness potency and structural characteristics of thyroid cancer cell lines Pathology - Research and Practice DOI 10.1016/j.prp.2022.154262
  9. 2023 The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line Pathology - Research and Practice DOI 10.1016/j.prp.2023.154385
  10. 2023 The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line Elsevier BV DOI 10.1016/j.prp.2023.154385
  11. 2023 The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line Elsevier BV DOI 10.1016/j.prp.2023.154385
  12. 2023 The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line Pathology - Research and Practice DOI 10.1016/j.prp.2023.154385
  13. 2023 Evaluation of IL-10, MCP-1, IFN gamma, and protectin D1 levels in patients with Hashimoto's thyroiditis Ir J Med
  14. 2023 The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line PATHOLOGY RESEARCH AND PRACTICE DOI 10.1016/j.prp.2023.154385
  15. 2023 Evaluation of IL-10, MCP-1, IFN gamma, and protectin D1 levels in patients with Hashimoto’s thyroiditis Irish Journal of Medical Science DOI 10.1007/s11845-022-03231-3
  16. 2023 Chitotriosidase Might Be A Diagnostic Marker In Patients With Hashimoto Thyroiditis INTERNATIONAL JOURNAL OF MEDICAL BIOCHEMISTRY DOI 10.14744/ijmb.2022.36036
  17. 2023 The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line Pathology - Research and Practice
  18. 2023 Chitotriosidase Might Be A Diagnostic Marker In Patients With Hashimoto Thyroiditis Kare Publishing DOI 10.14744/ijmb.2022.36036
  19. 2023 Chitotriosidase might be a diagnostic marker in patients with hashimoto thyroiditis INTERNATIONAL JOURNAL OF MEDICAL BIOCHEMISTRY DOI 10.14744/ijmb.2022.36036
  20. 2022 Probiotic kefir consumption improves serum apolipoprotein A1 levels in metabolic syndrome patients: a randomized controlled clinical trial Nutrition Research DOI 10.1016/j.nutres.2022.02.006

Akademisyenlere dön